Latest Industry Insights
Innovative Spectroscopy Is Enhancing Protein Structure Determination
Proteins are central to many disciplines within the life sciences, not least protein-based pharmaceuticals. Changes in protein conformation, structure or interactions could have significant impact on efficacy and safety. Therefore, being able to understand what forms of a protein are present in their natural conditions, even if present only at low levels, is important for analysts.
Lung Model Aids SARS-CoV-2 Research
An in vitro model of the human lung airway epithelium developed by Newcells Biotech is currently being tested as a platform for modeling SARS-CoV-2 infection. To learn more about the model and how it could help in the fight against SARS-CoV-2, Technology Networks spoke to Dr Mike Nicholds, CEO, Newcells Biotech.
Using Bioprinted Tissue Models To Test Drugs Against Diseases Including COVID-19
Technology Networks recently had the pleasure of speaking with Keith Murphy, CEO and founder of Viscient Biosciences to learn about the company's expertise in 3D disease models and multi-omics drug discovery approaches, and how they are using these techniques to test drugs against SARS-CoV-2 using bioprinted lung tissue.
Gene Therapy a New Paradigm for Healthcare: An Interview With bluebird bio
Technology Networks recently spoke with Martin Butzal, Head of Medical Europe at bluebird bio, to learn more about the exciting developments and key trends in the gene therapy space.
Making Allogeneic Cell Therapy a Reality for Patients: An Interview With Allogene Therapeutics
Technology Networks spoke with David Chang, MD, PhD, President, Chief Executive Officer and Co-Founder of Allogene to learn about the recent developments in the fast-developing allogeneic cell therapy research space and Allogene's visions for the future.
Leading the Movement Towards Direct Cell Conversion: An Interview With Mogrify
Technology Networks recently spoke with Joe Foster, COO, Mogrify, to learn about the biotech company's proprietary platform, the challenges encountered in developing cell therapies and to gain Mogrify's insights on the future of this exciting research space.
Looking to the Future of Cell and Gene Therapies
Technology Networks recently spoke with three of the leaders in the cell and gene therapy space, Allogene Therapeutics, bluebird Bio and Mogrify to gain their insights on the next developments in this space.
Cellular Agriculture – Moving Towards a More Sustainable Method of Milk Production
As part of efforts to provide a more sustainable method of milk production, TurtleTree Labs has developed a cellular method, which bypasses the environmental and animal welfare issues of industrial dairy. Technology Networks recently spoke with Fengru Lin, the founder of TurtleTree Labs, to learn more about the method and the benefits it could offer.
High Sensitivity Proteomics: Immunopeptidomics
Technology Networks recently spoke with Gary Kruppa, PhD, Vice President of Proteomics, Bruker Daltonics Inc., to learn more about the advancing research area immunopeptidomics, and to discuss the current status of single cell proteomics.
Proteomics Lends a Hand in the Fight Against COVID-19
Technology Networks spoke with Stephen Williams, Chief Medical Officer of SomaLogic, to learn about how proteomics can contribute to the fight against COVID-19 and the availability of the SomaScan Assay at this critical time.